KK
FLGT icon

KLP Kapitalforvaltning’s Fulgent Genetics FLGT Stock Holding History

KLP Kapitalforvaltning’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,300
Closed -$68.4K – 2167
2026
Q1 		$68.4K Hold
4,300
– – ﹤0.01% 2107
2025
Q4 		$113K Buy
4,300
+1,200
+39% +$31.1K ﹤0.01% 2042
2025
Q3 		$70.1K Hold
3,100
– – ﹤0.01% 2117
2025
Q2 		$61.6K Hold
3,100
– – ﹤0.01% 2137
2025
Q1 		$52.4K Hold
3,100
– – ﹤0.01% 2190
2024
Q4 		$57.3K Buy
+3,100
New +$60.5K ﹤0.01% 2221

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KLP Kapitalforvaltning's FLGT Position: Q2 2026 in Review

KLP Kapitalforvaltning sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 4,300 shares — an estimated $68.4K sold.

KLP Kapitalforvaltning first reported a position in FLGT in Q4 2024 and held it in 6 quarters. The position peaked at $113K in Q4 2025. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • KLP Kapitalforvaltning reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • KLP Kapitalforvaltning sold 4,300 Fulgent Genetics shares in Q2 2026, an estimated $68.4K.
  • KLP Kapitalforvaltning first reported a position in Fulgent Genetics in Q4 2024 and held it in 6 quarters.
  • KLP Kapitalforvaltning's Fulgent Genetics position peaked at $113K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.